Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer
E O'Sullivan, Anna Keogh, Brian E. Henderson, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1635-1635
Open Access | Times Cited: 42

Showing 26-50 of 42 citing articles:

The heterogenous landscape of EGFR Del19 mutation subtype: not all are the same for osimertinib
Boris Duchemann, Emmanuelle Fabre, Jordi Remón
Translational Lung Cancer Research (2024) Vol. 13, Iss. 4, pp. 952-955
Open Access
Discovery of novel coumarin-based KRAS-G12C inhibitors from virtual screening and Rational structural optimization
Jian-Tao Shi, Su-Juan Hou, Lei Cheng, et al.
Bioorganic Chemistry (2024) Vol. 148, pp. 107467-107467
Closed Access
Prevalence of KRAS Amplification in Patients with Metastatic Cancer: Real-world Next-Generation Sequencing Analysis
Dae-Ho Choi, Hye‐Lim Jang, Sung Hee Lim, et al.
Pathology - Research and Practice (2024) Vol. 261, pp. 155473-155473
Closed Access
Focal cortical dysplasia type IIIb associated with a KRAS-mutant ganglioglioma
Elena Repnikova, Lei Zhang, Brent A. Orr, et al.
Cancer Genetics (2024) Vol. 288-289, pp. 1-4
Closed Access
Vaccine-based therapeutic interventions in lung cancer management: A recent perspective
Dhruv Gupta, Daksh Sanjay Gupta, Nosheen Kamruddin Abjani, et al.
Medical Oncology (2024) Vol. 41, Iss. 11
Closed Access
Treatments that Target Cell Communication

(2024), pp. 109-182
Closed Access
Bringing Hope to Improve Treatment in Pancreatic Ductal Adenocarcinoma—A New Tool for Molecular Profiling of KRAS Mutations in Tumor and Plasma Samples
Ana Catarina Bravo, B Morão, André Luz, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3544-3544
Open Access
Evolving Patient-Centred Therapies for Metastatic NSCLC
OPEN Health Scientific Communications
EMJ Oncology (2024), pp. 39-48
Open Access
Impact of Nordihydroguaiaretic Acid on Proliferation, Energy Metabolism, and Chemosensitization in Non-Small-Cell Lung Cancer (NSCLC) Cell Lines
Carina Chipón, Paula Riffo, Loreto Ojeda, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11601-11601
Open Access
KRAS inhibitors in drug resistance and potential for combination therapy
Lala S. Rathod, Nikhil S. Sakle, Santosh N. Mokale
Tumori Journal (2024)
Closed Access
Mechanisms of treatment resistance in colorectal cancer
Benny Mosoane, Georgios Lolas, Zodwa Dlamini
Elsevier eBooks (2024), pp. 25-40
Closed Access
Expression of SPRED2 in the lung adenocarcinoma
Y. Ota, Tong Gao, Masayoshi Fujisawa, et al.
Pathology - Research and Practice (2024) Vol. 265, pp. 155721-155721
Closed Access
Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer
L. Amato, Daniela Omodei, Caterina De Rosa, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 3941-3941
Open Access
First-line treatments for KRAS-mutant non-small cell lung cancer: current state and future perspectives
Qi He, Xiaoyan Liu, Liyan Jiang, et al.
Cancer Biology & Therapy (2024) Vol. 26, Iss. 1
Open Access
Adagrasib in KRYSTAL-12 has Not Broken the KRAS G12C Enigma Code of the Unspoken 6-Month PFS Barrier in NSCLC
Alexandria TM Lee, Misako Nagasaka
Lung Cancer Targets and Therapy (2024) Vol. Volume 15, pp. 169-176
Open Access
Screening biomarkers for predicting the efficacy of immunotherapy in patients with PD-L1 overexpression
Xiaodan Zhu, Bo Yu, Yanli Shen, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 14, pp. 12965-12976
Open Access | Times Cited: 1
Update in Lung Cancer Molecular Pathology: Technological Advances and Clinical Practice
Paolo Graziano, Giulio Rossi
Cancers (2023) Vol. 15, Iss. 15, pp. 3812-3812
Open Access
Oncogenèse pulmonaire et bases biologiques des traitements ciblés
Hélène Blons, Audrey Lupo-Mansuet, Simon Garinet, et al.
Revue des Maladies Respiratoires Actualités (2023) Vol. 15, Iss. 2, pp. eS1-eS12
Closed Access
Previous Page - Page 2

Scroll to top